Delivery Order SPE2DB20D7059-SPE2DB25FQLV8
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,626.99 to AmerisourceBergen Drug Corp for the supply of Levothyroxine 88 mcg tablets in quantities of 1,000 units. This contract, awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, operates under a firm fixed-price structure with no set-aside designation. The delivery location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract under...
- The Defense Logistics Agency awarded a $5,609.93 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Levothyroxine 100 MCG vials, with completion targeted for July 31, 2025. This competitively awarded, non-set-aside contract reflects a firm fixed price arrangement and represents a child delivery order under AmerisourceBergen's larger indefinite delivery vehicle with DLA. The pharmaceutical product will be delivered to the contractor's corporate office location in...
- The Defense Logistics Agency awarded a $239,100 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 112 microgram levothyroxine tablets. Under this order, Amerisourcebergen will deliver 100 count bottles of the medication to a location in Conshohocken, Pennsylvania by June 23, 2023 in support of the DLA's medical supply needs. As a leading pharmaceutical distributor, Amerisourcebergen routinely fulfills delivery orders for prescription drugs and other medical products on...
- The Defense Logistics Agency awarded a delivery order valued at $3,224.85 to AmerisourceBergen Drug Corp for the supply of Levothyroxine 75 MCG Capsule in quantities of 30 units. The contract, issued on July 22, 2025, with an ultimate completion date of July 23, 2025, utilizes firm fixed price pricing and does not include a set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location in the same...
- The Defense Logistics Agency (DLA) awarded a $1,092.69 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of 4,563,189,790 units of 112 mcg Levothyroxine tablets. This contract, with an ultimate completion date of December 28, 2023, is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that specializes in supplying a wide range of medical products, including specialty medications,...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $2,482.87 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of 1,000 tablets of 150 mcg levothyroxine, a generic thyroid medication, with a completion date of March 8, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which was not designated as a set-aside...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Levothyroxine 137 MCG Tablets in 1,000-count quantities, with a ceiling value of $1,617.60 and a performance period through October 31, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
- The Defense Logistics Agency Troop Support Medical awarded a $58,380 firm fixed price delivery order to Amerisourcebergen Drug Corp for 100 tablets of 25 mcg Levothyroxine sodium. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The period of performance is September 13-14, 2023. Amerisourcebergen Drug Corp is a division of Amerisourcebergen Corporation, a major pharmaceutical distributor, which will fulfill this order for the thyroid medication to...
- This federal contract award, valued at $2,922.02, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of levothyroxin 100mcg tablets, a medication used to treat hypothyroidism, with a performance period through February 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $19,846.86 order is for the supply of Levothyroxine 50MCG tablets to support military treatment programs and facilities. This delivery order falls under a larger indefinite delivery contract that Amerisourcebergen holds with DLA Troop Support Medical to provide...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB25FQLV8Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,051.66 to AmerisourceBergen Drug Corp for the supply of Levothyroxine 137 mcg tablets (100-count units) with an ultimate completion date of July 22, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and was awarded on July 21, 2025. The contractor will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a $999.99 billion potential value through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen's extensive federal contract portfolio with the DLA demonstrates its established capability to supply a wide range of pharmaceutical products across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company competes successfully in open procurement for both routine medications and specialized medical supplies, positioning it as a critical vendor within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 7/21/25 |